As a group, equities analysts anticipate that STAAR Surgical will post 0.56 EPS for the current year.

Source: https://www.americanbankingnews.com/2023/11/04/janney-montgomery-scott-llc-takes-position-in-staar-surgical-nasdaqstaa.html

Canaccord Genuity Group downgraded shares of STAAR Surgical from a “buy” rating to a “hold” rating and lowered their price objective for the stock from $77.00 to $48.00 in a research report on Thursday, August 3rd.

Source: https://www.americanbankingnews.com/2023/09/17/needham-company-llc-cuts-staar-surgical-nasdaqstaa-price-target-to-52-00.html

Needham & Company LLC decreased their price target on STAAR Surgical from $52.00 to $49.00 and set a “buy” rating on the stock in a research note on Thursday.

Source: https://www.americanbankingnews.com/2023/11/04/janney-montgomery-scott-llc-takes-position-in-staar-surgical-nasdaqstaa.html

STAAR Surgical has a 52 week low of $46.35 and a 52 week high of $112.27.

Source: https://www.etfdailynews.com/2023/04/05/baillie-gifford-co-raises-position-in-staar-surgical-nasdaqstaa/